Syncona Shs GBP (GB:SYNC) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top StocksMake ...

"Slingshot represents an opportunity to bridge the gap between academic innovation and clinical development of a novel ...

Syncona has launched Slingshot Therapeutics with an initial $15 million investment through its Syncona Accelerator initiative ...

Syncona Ltd, (“Syncona”) a leading life science investor focused on creating, building and scaling global leaders in life science, today announces that it has launched a new portfolio company ...

(Alliance News) - Syncona Ltd on Thursday said it launched a new portfolio company as it reported a fall in net asset value, citing a weaker US dollar. The life science investor said net asset ...

(Sharecast News) - Syncona announced the launch of Slingshot Therapeutics, a new portfolio company and accelerator dedicated to developing early-stage life science programs sourced from academia ...

Fintel reports that on November 18, 2024, Goldman Sachs upgraded their outlook for Autolus Therapeutics plc - Depositary ...

Burberry Group continued to rally on Friday, a day after announcing a sweeping turnaround plan to save £40m and arrest its sales slump. Landscaping materials group Marshalls led the risers, while ...

It said Slingshot would remain wholly owned by Syncona, offering a capital-efficient and centralised structure to drive multiple preclinical projects towards clinical development. Slingshot’s ...